Фармакоэкономика (Aug 2017)

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

  • V. K. Fedyaeva,
  • V. V. Omelyanovskiy,
  • N. Z. Musina,
  • G. R. Khachatryan,
  • O. I. Ivakhnenko

DOI
https://doi.org/10.17749/2070-4909.2017.10.2.069-074
Journal volume & issue
Vol. 10, no. 2
pp. 69 – 74

Abstract

Read online

Among the most important aspects of the health policy are the methods for pricing of medicines, especially of innovative medicines. In many countries, the “therapeutic value” of a medicine is commonly used as a major criterion in negotiations on medicine prices. The existing tools for assessing the therapeutic value of medicines are not used in the Russian Federation. Here we propose a method for estimating the therapeutic value of innovative medicines based on the multi-criterial analysis.

Keywords